GlassScriptPhysician profile
Michael T Pugliese
NPI 1477559748
$4,413.27
in general payments reported to CMS, 2019-2025
48 companies · $1,634 in 2025
The $1,634 reported for 2025 was more than what 75% of Pediatric Endocrinology providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $90.12 · 2021: $284 · 2022: $324 · 2023: $1,163 · 2024: $757 · 2025: $1,634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,554.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $493.20 | 2024-2025 | Omnipod |
| Abbvie INC. | $324.09 | 2023-2025 | |
| Supernus Pharmaceuticals, INC. | $241.27 | 2022-2025 | Qelbree, Qelbree |
| Azurity Pharmaceuticals, INC. | $224.59 | 2023-2025 | Triptodur, Triptodur |
| Corium, LLC | $208.89 | 2022-2025 | Azstarys |
| Biomarin Pharmaceutical INC. | $205.17 | 2023-2024 | Voxzogo 1.2mg, Palynziq |
| Ucb, INC. | $174.10 | 2021-2025 | Briviact, Fintepla, Nayzilam |
| Abbott Laboratories | $171.27 | 2021-2025 | Freestyle Libre 3 |
| Tolmar, INC. | $153.67 | 2023-2025 | Fensolvi |
| Sanofi-Aventis U.S. LLC | $148.48 | 2021-2025 | |
| Xeris Pharmaceuticals, INC. | $148.27 | 2021-2023 | Gvoke Hypopen |
| Genzyme Corporation | $137.18 | 2021-2023 | |
| Ironshore Pharmaceuticals INC. | $127.24 | 2019-2024 | Jornay Pm |
| Novo Nordisk INC | $127.19 | 2019-2025 | Sogroya |
| Baxter Healthcare | $121.56 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Pugliese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.